|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Current assets: | |||||||||||||
| Cash | |||||||||||||
| Prepaid expenses | |||||||||||||
| Due from Sponsor | |||||||||||||
| Total current assets | |||||||||||||
| Investments held in Trust Account | |||||||||||||
| Deferred offering costs | |||||||||||||
| Total Assets | |||||||||||||
| Liabilities and Shareholders’ Deficit: | |||||||||||||
| Current liabilities: | |||||||||||||
| Accounts payable | |||||||||||||
| Related Party | |||||||||||||
| Total accounts payable | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Accrued expenses - related party | |||||||||||||
| Related Party | |||||||||||||
| Total accrued expenses - related party | |||||||||||||
| Note payable - related party | |||||||||||||
| Convertible promissory note, net of discount | |||||||||||||
| Related Party | |||||||||||||
| Nonrelated Party | |||||||||||||
| Promissory note - related party | |||||||||||||
| Promissory notes - related party | |||||||||||||
| Convertible promissory notes, net of discount | |||||||||||||
| Derivative liability - forward purchase | |||||||||||||
| Nonrelated Party | |||||||||||||
| Total derivative liability - forward purchase | |||||||||||||
| Total current liabilities | |||||||||||||
| Deferred underwriting commissions | |||||||||||||
| Warrant liabilities | |||||||||||||
| Total Liabilities | |||||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 509,341 and 6,315,949 shares issued and outstanding at approximately $10.73 and $10.72 per share redemption value as of March 31, 2024 and December 31, 2023, respectively | |||||||||||||
| Shareholders’ Deficit: | |||||||||||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of March 31, 2024 and December 31, 2023 | |||||||||||||
| Ordinary shares | |||||||||||||
| Common Class A | |||||||||||||
| Common Class B | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Total Shareholders’ Deficit | |||||||||||||
| Total Liabilities and Shareholders’ Deficit | |||||||||||||
Loading...
